Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:MPHTSE:VSN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMPHMedicureC$1.06-9.4%C$0.92C$0.63▼C$1.26C$11.06M0.94,381 shs1,000 shsVSNVeresenC$0.00C$11.40▼C$19.07C$5.81BN/A1.30 million shs1.15 million shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMPHMedicure0.00%-9.40%+21.84%+19.10%0.00%VSNVeresen0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMPHMedicureN/AN/AN/AN/AN/AN/AN/AN/AVSNVeresenN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMPHMedicure 0.00N/AN/AN/AVSNVeresen 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMPHMedicureC$21.08M0.52C$0.43 per share2.49C$1.91 per share0.55VSNVeresenN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMPHMedicure-C$2.03M-C$0.19N/A∞N/A-9.65%-10.18%-5.63%N/AVSNVeresenN/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMPHMedicureN/A2.24%N/AN/AN/AVSNVeresenC$1.005.27%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMPHMedicure4.652.031.29VSNVeresenN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMPHMedicure23.10%VSNVeresenN/AInsider OwnershipCompanyInsider OwnershipMPHMedicure26.68%VSNVeresenN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMPHMedicureN/A10.44 millionN/ANot OptionableVSNVeresen147,000314.00 millionN/ANot OptionableFUM, VSN, SCLP, and MPH HeadlinesRecent News About These CompaniesJordan Cove parent company looks at financing, ownership options, expansionSeptember 28, 2023 | theworldlink.comELD apologises after nearly 10,000 voters in Tanjong Pagar GRC receive two poll cards due to printer’s errorAugust 27, 2023 | channelnewsasia.comJordan Cove donates more than $300,000 to defeat measureMay 22, 2023 | theworldlink.comEncuentran al menos 60 cadáveres en provincia del Congo - ChronApril 26, 2023 | news.google.comVeresen (TSE:VSN) Stock Price Passes Above Two Hundred Day ... - Defense WorldApril 18, 2023 | news.google.comOregon DEQ opens comments on permit renewal for former Weyerhaeuser facilityApril 11, 2023 | theworldlink.comBidders Can Structure Offers To Discourage The Use Of Rights Of ... - Mondaq News AlertsApril 5, 2023 | news.google.comRecuperan 36 cadáveres en un pozo tras derrumbe en India - Hartford City News TimesMarch 31, 2023 | news.google.comThe Right Of First Refusal And Good Faith In Your Business Contract ... - Mondaq News AlertsMarch 29, 2023 | news.google.comBidders can Structure Offers to Discourage the Use of Rights of First ... - LexologyMarch 28, 2023 | news.google.comPembina Pipeline : Gas Infrastructure - Marketscreener.comMarch 27, 2023 | news.google.comBidders can Structure Offers to Discourage the Use of Rights of First ... - McMillan LLPMarch 27, 2023 | news.google.comBBC Sounds - Assignment - Available EpisodesMarch 25, 2023 | bbc.co.ukThe Right of First Refusal and Good Faith in Your Business Contract ... - LexologyMarch 21, 2023 | news.google.comLiquefied Natural Gas Market to See Massive Growth by 2029 ... - Digital JournalMarch 14, 2023 | news.google.comNatural Gas Market Booming Worldwide( Forecast Period 2023-2029) With Top Player:BG Group plc, Apache Corporat - openPRMarch 14, 2023 | news.google.comLong-term supply agreements and high inflation — what businesses ... - McCarthy Tétrault LLPMarch 9, 2023 | news.google.comCEN: Reasonable CEF, But The Private Position Could Be A ... - Seeking AlphaMarch 8, 2023 | news.google.comInsights and Takeaways From Our Top 10 Commercial Litigation ... - LexologyFebruary 28, 2023 | news.google.comGlobal Natural Gas Market Industry Analysis, Size, Share, Demand ... - Taiwan NewsFebruary 27, 2023 | news.google.comMedia Sentiment Over TimeFUM, VSN, SCLP, and MPH Company DescriptionsMedicure CVE:MPHC$1.06 -0.11 (-9.40%) As of 06/9/2025Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.Veresen TSE:VSNVeresen Inc is a Canada-based energy infrastructure company that owns and operates energy infrastructure assets across North America. The Company is engaged in three principal businesses: a pipeline transportation business consists of interests in the Alliance Pipeline, the Ruby Pipeline and the Alberta Ethane Gathering System (AEGS); a midstream business, which includes a partnership interest in Veresen Midstream Limited Partnership, which owns assets in western Canada, and an ownership interest in Aux Sable, which owns a natural gas liquids (NGL) extraction facility near Chicago, and other natural gas and NGL processing energy infrastructure, and a power business consists of a portfolio of assets in Canada. The Company's segments include Pipelines, Midstream, Power and Corporate. Alliance Pipeline owns and manages an integrated, high-pressure natural gas and NGL pipeline. Ruby Pipeline is a natural gas transmission system. AEGS is an integrated pipeline system. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Fastenal Stock After Split: Poised for 5 More Years of Gains Analysts Love Lovesac, But Investors Should Be Cautious Oracle’s Cloud Boom Is Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
